Natixis’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$149K Sell
6,380
-799,809
-99% -$14.5M ﹤0.01% 928
2025
Q4
$11.4M Buy
+806,189
New +$15.3M 0.04% 314
2025
Q3
Sell
-409,447
Closed -$9.29M 1059
2025
Q2
$9.29M Buy
+409,447
New +$9.7M 0.04% 251
2024
Q4
Sell
-86,997
Closed -$5.52M 1030
2024
Q3
$5.52M Buy
+86,997
New +$6.28M 0.03% 295
2024
Q2
Sell
-106
Closed -$8.4K 979
2024
Q1
$8.4K Buy
106
+20
+23% +$1.64K ﹤0.01% 901
2023
Q4
$6.69K Buy
+86
New +$6.37K ﹤0.01% 935
2017
Q4
Sell
-5,380
Closed -$257K 825
2017
Q3
$257K Buy
5,380
+283
+6% +$13.8K ﹤0.01% 984
2017
Q2
$252K Buy
+5,097
New +$226K ﹤0.01% 691

Other funds holding ACHC

Natixis's ACHC Position: Q1 2026 in Review

Natixis reduced its Acadia Healthcare (ACHC) stake by 99% in Q1 2026, selling an estimated $14.5M and leaving 6,380 shares worth $149K. The position accounts for ﹤0.01% of the portfolio, ranked #928.

Natixis first reported a position in ACHC in Q2 2017 and has held it in 8 quarters since. The position peaked at $11.4M in Q4 2025. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

  • Natixis held 6,380 shares of Acadia Healthcare worth $149K as of Q1 2026.
  • Natixis sold 799,809 Acadia Healthcare shares in Q1 2026, an estimated $14.5M.
  • Acadia Healthcare made up ﹤0.01% of Natixis's portfolio in Q1 2026, its #928 holding.
  • Natixis first reported a position in Acadia Healthcare in Q2 2017 and has held it in 8 quarters since.
  • Natixis's Acadia Healthcare position peaked at $11.4M in Q4 2025.
  • 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.